Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saskia Middeldorp

Showing results (311-320 of 342) with videos related to

Pageof 35
Sort By:
Thrombosis Research|October 23, 2021
Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort studyThijs F van Haaps, Didier Collard, Frits H M van Osch, et al.
Journal of the American College of Cardiology|January 17, 2024
When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art ReviewAntoine Bejjani, Candrika D Khairani, Ali Assi, et al.
The New England Journal of Medicine|March 21, 2019
Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary EmbolismLiselotte M van der Pol, Cecile Tromeur, Ingrid M Bistervels, et al.
The Lancet. Haematology|December 9, 2017
Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trialArina J Ten Cate-Hoek, Elham E Amin, Annemieke C Bouman, et al.
Trials|May 8, 2015
ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trialPaulien G de Jong, Siobhan Quenby, Kitty W M Bloemenkamp, et al.
The New England Journal of Medicine|February 8, 2019
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa InhibitorsStuart J Connolly, Mark Crowther, John W Eikelboom, et al.
Lancet (London, England)|May 28, 2017
Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort studyTom van der Hulle, Whitney Y Cheung, Stephanie Kooij, et al.
Seminars in Thrombosis and Hemostasis|January 4, 2024
Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A ReviewBehnood Bikdeli, Parham Sadeghipour, Junyang Lou, et al.
Journal of Vascular Research|April 17, 2024
The Incidence of Pulmonary Embolism in Hospitalized Non-ICU Patients with COVID-19 during the First Wave: A Multicenter Retrospective Cohort Study in the NetherlandsArno F G Maas, Caroline Wyers, Arne Dielis, et al.
Research and Practice in Thrombosis and Haemostasis|July 19, 2021
Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarinRoisin Bavalia, Ingrid M Bistervels, Wim G Boersma, et al.
Pageof 35

Showing results (311-320 of 342) with videos related to

Sort By:
Pageof 35
Thrombosis Research|October 23, 2021
Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort studyThijs F van Haaps, Didier Collard, Frits H M van Osch, et al.
Journal of the American College of Cardiology|January 17, 2024
When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art ReviewAntoine Bejjani, Candrika D Khairani, Ali Assi, et al.
The New England Journal of Medicine|March 21, 2019
Pregnancy-Adapted YEARS Algorithm for Diagnosis of Suspected Pulmonary EmbolismLiselotte M van der Pol, Cecile Tromeur, Ingrid M Bistervels, et al.
The Lancet. Haematology|December 9, 2017
Individualised versus standard duration of elastic compression therapy for prevention of post-thrombotic syndrome (IDEAL DVT): a multicentre, randomised, single-blind, allocation-concealed, non-inferiority trialArina J Ten Cate-Hoek, Elham E Amin, Annemieke C Bouman, et al.
Trials|May 8, 2015
ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trialPaulien G de Jong, Siobhan Quenby, Kitty W M Bloemenkamp, et al.
The New England Journal of Medicine|February 8, 2019
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa InhibitorsStuart J Connolly, Mark Crowther, John W Eikelboom, et al.
Lancet (London, England)|May 28, 2017
Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort studyTom van der Hulle, Whitney Y Cheung, Stephanie Kooij, et al.
Seminars in Thrombosis and Hemostasis|January 4, 2024
Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A ReviewBehnood Bikdeli, Parham Sadeghipour, Junyang Lou, et al.
Journal of Vascular Research|April 17, 2024
The Incidence of Pulmonary Embolism in Hospitalized Non-ICU Patients with COVID-19 during the First Wave: A Multicenter Retrospective Cohort Study in the NetherlandsArno F G Maas, Caroline Wyers, Arne Dielis, et al.
Research and Practice in Thrombosis and Haemostasis|July 19, 2021
Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarinRoisin Bavalia, Ingrid M Bistervels, Wim G Boersma, et al.
Pageof 35